Skip to main content
Top
Published in: Medical Oncology 1/2011

01-12-2011

The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions

Authors: Min-Zhu Huang, Shuang Huang, Deng-Qing Li, Xin-Min Nie, Hong-Bo Li, Xiao-Man Jiang

Published in: Medical Oncology | Special Issue 1/2011

Login to get access

Abstract

The objective of this study is to detect the infection of human papillomavirus (HPV) and the expression of p16INK4a in cervical lesions and to investigate the interaction between hrHPV and p16INK4a for cervical lesions and its diagnostic efficiency. hrHPV-DNA was detected by the hybrid capture II (HC-II) system. Immunochemical method was used to detect the expression of p16INK4a, and histopathologic test was performed to identify cervical lesions. χ 2 test and Spearman’s rank correlation were used for statistical analysis. Additive effects model was used to analyze the interaction. The diagnostic sensitivity, specificity, positive predictive values, negative predictive values, accuracy, and the area under the receiver operating characteristic curve were calculated with SPSS 13.0. hrHPV and p16INK4a positive rate increased (P < 0.05) with histopathologic diagnosis increasing. The positive rates of hrHPV and p16INK4a in negative or chronic inflammation were statistically lower than that in cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, and squamous-cell carcinoma (SCC) (P < 0.05), respectively. There was a positive interaction between hrHPV and p16INK4a, relative excess risk of interaction (RERI) was 52.49, attributable proportions of interaction (API) were 72.34%, and the synergy index (S) was 3.75. The specificity and AUC of combining hrHPV with p16INK4a were statistically higher than hrHPV or p16INK4a alone (P < 0.05). hrHPV and p16INK4a are useful markers for the early diagnosis of cervical lesions. A positive interaction between hrHPV and p16INK4a is seen. The combination of hrHPV and p16INK4a has a higher diagnostic accuracy than hrHPV or p16INK4a alone in diagnosis of cervical lesions.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Global Cancer 2000. Int J Cancer. 2001;94:153–6.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Global Cancer 2000. Int J Cancer. 2001;94:153–6.PubMedCrossRef
2.
go back to reference Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.PubMedCrossRef Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.PubMedCrossRef
3.
go back to reference Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.PubMedCrossRef Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.PubMedCrossRef
4.
go back to reference Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107:S2–S5.PubMedCrossRef Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107:S2–S5.PubMedCrossRef
5.
go back to reference Jedpiyawongse A, Homcha-em P, Karalak A, Srivatanakul P. Immunohistochemical overexpression of P16 protein associated with cervical cancer in Thailand. Asian Pac J Cancer Prev. 2008;9:625–30.PubMed Jedpiyawongse A, Homcha-em P, Karalak A, Srivatanakul P. Immunohistochemical overexpression of P16 protein associated with cervical cancer in Thailand. Asian Pac J Cancer Prev. 2008;9:625–30.PubMed
6.
go back to reference Negri G, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. Am J Surg Pathol. 2003;27:187–93.PubMedCrossRef Negri G, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. Am J Surg Pathol. 2003;27:187–93.PubMedCrossRef
7.
go back to reference Shi J, et al. Evaluation of p16INK4a, minichromosome maintenanceprotein2, DNA topoisomerase IIA, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol. 2007;38:1335–44.PubMedCrossRef Shi J, et al. Evaluation of p16INK4a, minichromosome maintenanceprotein2, DNA topoisomerase IIA, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol. 2007;38:1335–44.PubMedCrossRef
8.
go back to reference Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364:249–56.PubMedCrossRef Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364:249–56.PubMedCrossRef
9.
go back to reference Munoz N, et al. Epidemiologic classification of human papillo-mavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27.PubMedCrossRef Munoz N, et al. Epidemiologic classification of human papillo-mavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27.PubMedCrossRef
10.
go back to reference Huang MZ, et al. Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions. Trans R Soc Trop Med Hyg. 2009;103:779–84.PubMedCrossRef Huang MZ, et al. Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions. Trans R Soc Trop Med Hyg. 2009;103:779–84.PubMedCrossRef
11.
go back to reference Woodman CB, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001;357:1831–6.PubMedCrossRef Woodman CB, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001;357:1831–6.PubMedCrossRef
12.
go back to reference Bolanca IK, Ciglar S. Evaluation of p16INK4a in cervical lesion of premenopausal and postmenopausal women. Coll Antropol. 2007;2:107–11. Bolanca IK, Ciglar S. Evaluation of p16INK4a in cervical lesion of premenopausal and postmenopausal women. Coll Antropol. 2007;2:107–11.
13.
go back to reference Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol. 2000;2:E65–7.PubMedCrossRef Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol. 2000;2:E65–7.PubMedCrossRef
14.
go back to reference Zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.PubMedCrossRef Zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.PubMedCrossRef
15.
go back to reference Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J. 2005;46(5):597–613.PubMedCrossRef Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J. 2005;46(5):597–613.PubMedCrossRef
16.
go back to reference Kalof AN, Cooper K. p16INK4a immunoexpression: Surrogate markerof high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol. 2006;13:190–4.PubMedCrossRef Kalof AN, Cooper K. p16INK4a immunoexpression: Surrogate markerof high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol. 2006;13:190–4.PubMedCrossRef
17.
go back to reference Monsonego J, et al. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear. Acta Cytol. 2007;51:755–66.PubMedCrossRef Monsonego J, et al. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear. Acta Cytol. 2007;51:755–66.PubMedCrossRef
18.
go back to reference Arrieta O, et al. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer. 2007;8:28.CrossRef Arrieta O, et al. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer. 2007;8:28.CrossRef
Metadata
Title
The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions
Authors
Min-Zhu Huang
Shuang Huang
Deng-Qing Li
Xin-Min Nie
Hong-Bo Li
Xiao-Man Jiang
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue Special Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9705-y

Other articles of this Special Issue 1/2011

Medical Oncology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.